Globus Medical (GMED) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Globus Medical Reports Second Quarter 2017 Results
August 2, 2017 4:30 PM EDTAUDUBON, Pa., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions manufacturer, today announced its financial results for the second quarter ended June 30, 2017.
Worldwide sales were $152.4 million, an increase of 10.8% as reported, or 11.0% in constant currencySecond quarter net income was $28.7 million, or 18.8% of salesDiluted earnings per share (EPS) were $0.29Non-GAAP diluted EPS were $0.32Non-GAAP adjusted EBITDA was 35.1% of salesDavid Paul, Chairman and CEO said, Our worldwide sales for the second quarter were $152.4 million, an increase of 10.8%... More
